Method

Single-cell transcriptome analysis reveals onco-fetal reprogramming with implications for drug resistance and clinical outcome

    • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang 150081, China;
    • 2Thoracic Oncology Institute, Peking University People's Hospital, Beijing 100044, China;
    • 3Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China;
    • 4Research Unit of Intelligence Diagnosis and Treatment in Early Non-Small Cell Lung Cancer, Chinese Academy of Medical Sciences, 2021RU002, Peking University People's Hospital, Beijing 100044, China;
    • 5Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China;
    • 6Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China;
    • 7Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang 150028, China;
    • 8School of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin, Heilongjiang 150081, China
    • 9 These authors contributed equally to this work.
Published October 9, 2026. https://doi.org/10.1101/gr.281292.125
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 10
Current Issue:

Abstract

Onco-fetal (OF) reprogramming of the tumor ecosystem induces fetal-like characteristics, leading to tumor growth and malignant progression. Here, we develop a robust computational pipeline to systematically identify OF cells, using single-cell transcriptomic data from corresponding fetal and tumor tissues across multiple cancer types. OF cells are consistently detected across diverse malignancies and exhibit pronounced stem-like properties. Core transcription factors involved in OF reprogramming are identified, including PTMA, ATF5, TCF4, and FOS, whose coordinated activities may promote tumor progression. Strategically positioned OF cells orchestrate tumor microenvironment cross talk, specifically impairing B cell function. OF cells are further verified in additional cancers, and we find that high OF cell abundance contributes to enhanced drug resistance and cancer recurrence. Critically, pancancer analyses establish that OF cell markers universally portend adverse prognoses. Overall, our study uncovers a clinically consequential cancer cell subpopulation and highlights its potential as a target for precision oncology.

Loading
Loading
Back to top